Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

BACKGROUND: The aim of this study was to compare the efficacy, safety, costs, and cost-effectiveness of biphasic insulin aspart 30 (BIAsp 30) with NPH plus regular human insulin (NPH/Reg) in patients with type 2 diabetes mellitus (T2DM). METHODS: It was a Single-center, parallel-group, randomized, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Farshchi, Amir, Aghili, Rokhsareh, Oskuee, Maryam, Rashed, Marjan, Noshad, Sina, Kebriaeezadeh, Abbas, Kia, Maryam, Esteghamati, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899904/
https://www.ncbi.nlm.nih.gov/pubmed/27278922
http://dx.doi.org/10.1186/s12902-016-0116-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899904/
https://www.ncbi.nlm.nih.gov/pubmed/27278922
http://dx.doi.org/10.1186/s12902-016-0116-8

Ejemplares similares